Novartis, SkyePharma receive FDA approval for asthma spray Foradil
BASEL (AFX) - Novartis (nyse: NVS) AG and joint venture partner SkyePharma PLC (nasdaq: SKYE) have received market approval for their asthma spray Foradil Certihaler from the US Food and Drug Administration (FDA), following modifications to the product.
The product was recalled in Germany and Switzerland early this year on concern the inhaler was delivering variable doses of the drug.
SkyePharma has since been modifying the device and resubmitted it with the US regulator.
Continue reading "Novartis, SkyePharma receive FDA approval for asthma spray Foradil" »
Patients with obstructive lung diseases receive only about 55 percent of recommended medical care, according to a study that reflects the increasing health-care challenges of an aging population. 
ISLAMABAD - Preschool children who regularly snore are more likely to have asthma and nocturnal cough than those who do not snore, according to the results of a study published in the August issue of Chest. 
GENEVA, Switzerland, Dec. 15 -- A common cold virus can be deadly for lung-transplant recipients, reported researchers here. 
Ragweed allergies makes millions of us miserable with symptoms from red, watery eyes to excessive sneezing. But now a new treatment could soon leave you allergy-free.
A recent report by the EU-backed Network of Excellence GA2LEN, Global Allergy and Asthma European Network, highlights new suspected linkages between diet and allergies, particularly in children. Experts suggest that there has been a fundamental shift in European diets over the past twenty to forty years exposing children and adults alike to greater risks of allergies. Such findings by the nutrition network are indicators of the fresh research the network can contribute to this complex field.
Nearly one in 10 American children now has 
Subscribe to feed